O-045: Increasing hepatitis C testing uptake with point of care testing from the needle and syringe exchange desk - lessons learned from the Rapid-EC Feasibility Study

2018 ◽  
Vol 25 ◽  
pp. 28-29
2014 ◽  
Vol 3 (2) ◽  
pp. 295-306 ◽  
Author(s):  
Simon D. Goldenberg ◽  
Karen N. Bisnauthsing ◽  
Amita Patel ◽  
Anne Postulka ◽  
Duncan Wyncoll ◽  
...  

2020 ◽  
Vol 144 (11) ◽  
pp. 1372-1380
Author(s):  
Mark Shephard ◽  
Anne Shephard ◽  
Susan Matthews ◽  
Kelly Andrewartha

Context.— Point-of-care (POC) testing has significant potential application in rural and remote Australian communities where access to laboratory-based pathology testing is often poor and the burden of chronic, acute, and infectious disease is high. Objective.— To explore the clinical, operational, cultural, and cost benefits of POC testing in the Australian rural and remote health sector and describe some of the current challenges and limitations of this technology. Data Sources.— Evidence-based research from established POC testing networks for chronic, acute, and infectious disease currently managed by the International Centre for Point-of-Care Testing at Flinders University are used to highlight the experience gained and the lessons learned from these networks and, where possible, describe innovative solutions to address the current barriers to the uptake of POC testing, which include governance, staff turnover, maintaining training and competency, connectivity, quality testing, sustainable funding mechanisms, and accreditation. Conclusions.— Point-of-care testing can provide practical and inventive opportunities to revolutionize the delivery of pathology services in rural and remote sectors where clinical need for this technology is greatest. However, many barriers to POC testing still exist in these settings, and the full potential of POC testing cannot be realized until these limitations are addressed and resolved.


2021 ◽  
Vol 116 (1) ◽  
pp. S1392-S1392
Author(s):  
Janice Cheong ◽  
Michelle L. Hughes ◽  
Krystle Bittner ◽  
Christopher Walker ◽  
Sarah Enslin ◽  
...  

2015 ◽  
Vol 3 (4) ◽  
pp. 364-370 ◽  
Author(s):  
Manik Sharma ◽  
Saad Al Kaabi ◽  
Anil K John ◽  
Nazeeh Al Dweik ◽  
Hameed Ullah Wani ◽  
...  

2021 ◽  
Vol 24 (2) ◽  
pp. 94-100
Author(s):  
Mohammad Reza Hedayati-Moghaddam ◽  
Hossein Soltanian ◽  
Majid Danaee ◽  
Seyed Ahmad Vahedi

Background: People who use drugs, particularly injection drug users (IDUs) are known as the major source of hepatitis C virus (HCV) infection. This study was performed to determine the prevalence of HCV infection using rapid point-of-care testing and to assess liver fibrosis by non-invasive lab tests among addict populations of Mashhad, Iran. Methods: In this cross-sectional study, drug users who referred to drug treatment and harm reduction centers of Mashhad were enrolled during March and December 2019. A rapid test kit was used to assess the presence of anti-HCV antibodies and a real-time PCR was performed to confirm the infection. The AST-platelet ratio index (APRI) and fibrosis-4 (FIB-4) score were used to investigate liver fibrosis in patients with positive HCV RNA. A P value <0.05 was considered as significant. Results: A total of 390 drug users aged 15–74 years were assessed. Sixty-four individuals showed positive results for anti-HCV (16.4%), of whom 58 blood samples were available for PCR test. The viremic rate among the latter group was calculated at 84.5% (49/58); the total viremia prevalence was 12.8% (49/384). Multivariate analysis revealed that being single (P = 0.040) or divorced/ widow (P = 0.011) and history of drug injection (P<0.001) and tattoos (P = 0.021) were significantly associated with current HCV infection. Using APRI and FIB-4 indices, significant liver fibrosis was identified in 14.3% and 18.4% of cases, respectively. Conclusion: HCV infection screening using rapid tests and examining liver fibrosis by non-invasive lab tests appear to be practicable and useful among poor populations in settings such as drug treatment centers.


Author(s):  
Debrah I. Boeras ◽  
Rosanna W. Peeling

It is important to consider the role of diagnostics and the critical need for quality diagnostics services in resource-limited settings. Accurate diagnostic tests play a key role in patient management and the prevention and control of most infectious diseases. As countries plan for implementation of HIV early infant diagnosis and viral load point-of-care testing, the London School of Hygiene & Tropical Medicine has worked with countries and partners with an interest in external quality assurance to support quality point-of-care testing on the continent. Through a series of collaborative consultations and workshops, the London School of Hygiene & Tropical Medicine has gathered lessons learned, tools, and resources and developed quality assurance models that will support point-of-care testing. The London School of Hygiene & Tropical Medicine is committed to the continued advancement of laboratory diagnostics in Africa and quality laboratory services and point-of-care testing.


2018 ◽  
Vol 68 ◽  
pp. S255-S256
Author(s):  
V. Calvaruso ◽  
F. Bronte ◽  
D. Ferraro ◽  
M.G. Bavetta ◽  
S. Petta ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document